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The original cohort
The English Longitudinal Study of Ageing (ELSA) is an on-
going nationally representative sample of individuals
aged 50 and older living in England.1 The study started in
2002, and participants are reassessed every 2 years with
face-to-face interviews and self-completion questionnaires.
Biomedical assessments take place every 4 years with a
home visit from a study nurse who assesses functional ca-
pacity and anthropometry and takes blood samples for the
extraction of biomarkers and DNA. More than 18 000
people have taken part in the study since its inception, and
the data currently available span over 16 years (wave 9
took place in 2018/19). Refreshment samples of new par-
ticipants have been recruited at waves 3, 4, 6, 7 and 9 to
maintain the age profile and ensure that the study remains
representative of the English population aged 50 and over.
ELSA tracks multiple and complex characteristics of the
same individuals as they move through middle age to older
age and has collected a wide range of clinical, biological,
psychological, economic and social measures, including
biomarker and genetic data across the main waves. The
study is a collaboration between epidemiology and behav-
ioural science (University College London), economics
(Institute for Fiscal Studies), social science (University of
Manchester), clinical medicine (Norwich Medical School)
and survey specialists (NatCen Social Research). For up-
to-date information, see the study website [https://www.
elsa-project.ac.uk/]. ELSA data are archived with the UK
Data Service [https://ukdataservice.ac.uk] within a few
months of completion of each wave, and are accessed by
researchers and policy analysts around the world. The
study informs policy across many aspects of ageing, includ-
ing health and social care, retirement and pensions policy
and social and civic participation. Internationally, ELSA is
one of the sister studies of the Health and Retirement
Study (HRS) in the USA, and part of a growing network of
longitudinal population studies of ageing around the
world. These surveys not only provide data for individual
countries but also offer the opportunity for cross-national
comparisons of harmonized datasets. For more
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information, see the Gateway to Global Ageing Data web-
site [https://g2aging.org/].
Ethics Approval
The ELSA-HCAP Sub-study received ethical approval from
the South Central-Berkshire National Health Services (NHS)
Research Ethics Committee and was conducted in accordance
with the ethical standards of the Declaration of Helsinki.
Informed verbal consent was obtained from all participants or
their guardians. For more information see Supplementary ma-
terial available as Supplementary data at IJE online.
What is the reason for the new data
collection?
One of the key epidemiological challenges in the 21st cen-
tury is that non-communicable diseases, such as cardiovascu-
lar disease, stroke and dementia, have become the leading
causes of mortality and morbidity.2 Among these, dementia
represents one of the most debilitating conditions, with an
increased prevalence in individuals aged 65 years and older
and double risk with every 5 years’ increase in age after that.
Attributable pathologies accounting for dementia at death
suggest that age, brain atrophy, total volume loss, vascular
changes and disease-related proteins such as TDP-43 and
alpha-synuclein all contribute, with Alzheimer’s type pathol-
ogy alone accounting for only around 20% of cases.3 Early
detection and prevention are crucial but challenging, consid-
ering the interplay of the established risk factors operating at
various points across the life course.4
The operationalization of diagnostic criteria for the
ever-changing concepts of mild cognitive impairment and
dementia, as well as their diagnostic boundaries, are com-
plex. Yet in most cases, diagnosis involves a medical his-
tory and reported or measured changes in cognitive
function, as well as behavioural and functional impair-
ments that allow clinicians to gauge the severity of the
symptoms presented. A significant challenge is to define
what constitutes the normal spectrum of cognitive ageing
in contrast to cognitive impairment while taking into con-
sideration specific population norms.5 Despite our ability
to identify certain brain pathologies in vivo using neuroim-
aging and biomarkers,6 a precise diagnostic algorithm
remains problematic. The most significant difficulties en-
countered in diagnosing dementias stem principally from
their shared heterogeneous classifications, influenced by
multiple and mixed pathologies. Modern conceptualiza-
tions highlight preclinical stages reflecting changes that
have already taken place in the brain before marked symp-
toms emerge.7 Crucially, individuals who are clinically di-
agnosed are only a subset of those with cognitive
impairment and dementia, and it is estimated that demen-
tia remains undetected in almost 50% of primary care
patients in the UK,8 with even higher rates in other coun-
tries. In the absence of a single measurement instrument
for dementia identification and classification, international
efforts are being made to implement standardized neuro-
cognitive assessments in various population studies.
The implementation of the international Harmonised
Cognitive Assessment Protocol (HCAP) in the family of
studies associated with the Health and Retirement Study
offers an opportunity for investigating, in a comparable
manner, measures relevant to dementia diagnosis including
cognitive, sensory and psychological performance as well
as functional abilities in large representative population
samples of older adults in both high- and middle-income
countries. The overall aim of HCAP is to ascertain and in-
vestigate mild cognitive impairment and dementia across
the general population worldwide. HCAP involved much
more detailed assessments of cognitive impairment and its
correlates than was possible in the main waves of ELSA
and so was carried out as a sub-study. ELSA-HCAP pro-
vides opportunities for identifying potential predictors of
cognitive impairment and dementia, as well as the conse-
quences of dementia, in the context of the longitudinal
framework of ELSA main waves.
What will be the new areas of research?
The ELSA-HCAP protocol involves an extensive range of
cognitive measures coupled with informant interviews on a
stratified sub-sample of ELSA participants aged 65 and
older. These cognitive measures will be included in an in-
ternational algorithm aimed to classify dementia, mild cog-
nitive impairment and healthy cognitive function in
population studies, with benchmarking against the
Cognitive Function and Ageing Study (CFAS), the Aging
Demographics and Memory Study (ADAMS) and other
studies of cognitive ageing and dementia around the world.
The HCAP instrument aims to use international algo-
rithmic approaches to evaluate the prevalence of neurocog-
nitive disorders in people aged over 65 years within each
participating country including England, USA, Mexico,
South Africa, China and India. Currently, the HCAP
Network research group is developing a diagnostic algo-
rithm that will make use of HCAP respondent and infor-
mant data to assign a research diagnosis of normal, mild
cognitive impairment or dementia.
The HCAP project is being carried out in several coun-
tries around the world, and as a result, the international
implementation of these assessments offers the opportunity
for cross-national investigations and comparisons of the bi-
ological, medical, social and environmental factors that
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affect the risk of neurocognitive impairments. Therefore,
HCAP represents a promising international platform for
investigating and tracking changes in the prevalence of
mild cognitive impairment and dementia over time, facili-
tating country-specific investigations of medical care sys-
tems and social policy interventions.
Who is in the cohort?
Participants were selected for the ELSA-HCAP Sub-study if
they were an ELSA core member aged 65 and over at the
start of fieldwork in January 2018 (born before 1 January
1953) and had completed an ELSA interview in person at ei-
ther wave 8 (2016–17) or wave 7 (2014–15). Core members
living in care or nursing homes were also eligible, if they had
the capacity to consent, or if a consultee/family member
agreed to participate on their behalf. Further selections were
made based on a sample procedure related to their previous
cognitive performance using the modified Telephone
Interview Cognitive Screening (mTICS)9 and a diagnosis of
Alzheimer’s disease or dementia previously reported (waves
1–8). Three groups were defined using the thresholds on the
mTICS 27 items scale: group 1—low cognition (6
mTICS27 score) and/or a diagnosis of Alzheimer’s disease or
dementia; group 2—moderate cognition (7–11 mTICS27
score) and had never reported a diagnosis of Alzheimer’s dis-
ease or dementia; group 3—normal cognition (12
mTICS27 score) or unknown for those with missing data on
mTICS scores at most recent ELSA waves. ELSA-HCAP was
administered to participants across all the range of cognitive
abilities, but we oversampled those identified as having low
cognitive scores in the most recent ELSA waves. Core mem-
bers who had proxy interviews (indicating an inability to
participate themselves) at both wave 7 and wave 8 were not
eligible for ELSA-HCAP.
ELSA-HCAP dress rehearsal and fieldwork
The fieldwork for ELSA-HCAP took place between January
2018 and April 2018, between the ELSA main waves 8 and
9 (Supplementary Figure S1, available as Supplementary
data at IJE online). To test the design, materials and proce-
dure for the ELSA-HCAP Sub-study, a dress rehearsal was
conducted between August and September 2017. For more
information, see Supplementary material, available as
Supplementary data at IJE online.
ELSA-HCAP participants selection and response
rates
Based on the eligibility criteria, around 1800 individuals
were sampled for ELSA-HCAP, with the expectation of a
60% response rate. Around half (n¼ 900) were sampled
from cognitive groups 1 (low) and 2 (moderate). Since the
number of people eligible for group 1 (n¼ 334) was small,
all eligible members were invited, whereas for those eligi-
ble in group 3 (n¼ 4 610) only 1 in 5 people were invited.
The response rate for the ELSA-HCAP study was higher
than anticipated. From the 1684 eligible cases, 1273 com-
pleted the face-to-face interview, representing a final re-
sponse rate of 75.6% (Figure 1). Table 1 shows that
response rates were generally similar across age and sex,
but with a slightly higher response within the 65–69 age
group and lower in the 85þ age group.
ELSA-HCAP informants selection and response
rates
A total of 1050 informant interviews were conducted, rep-
resenting a response rate of 82.5% of all the eligible sam-
ple (n¼ 1273) contacted. Of these, 194 (18.5%) informant
interviews were completed by telephone, and 856 (81.5%)
by self-completion questionnaire. The informant relation-
ships with the respondent included spouse/partner (56%),
child (22%), grandchild (1%), sibling (3%), parent (3%),
friend (10%), carer (0.3%), neighbour (1%) or other
(3%). A small number refused to answer (0.4%). The aver-
age period an informant reported knowing the respondent
was 43 years [standard deviation (SD)¼ 18; range¼1–82].
Table 2 also shows the response rates among the informant
sampling groups (eligible and completed interviews),
which were similar across age and sex, with slightly lower
rates for informants aged 80 and over.
Sample weights
A weighting procedure was derived for the ELSA-HCAP
Sub-study in order to adjust for non-response bias within
each of the three cognition groups, especially for the low
cognition group, which had the lowest response rate. It in-
volved three components: design weights, non-response
weights and a calibration procedure accounting for differ-
ential selection probabilities and adjusting for non-
response. The final weight for this sub-study represents a
combination of the design and non-response weights,
which is made available to the users with the ELSA-HCAP
data (Supplementary data and Supplementary Table S1,
available at IJE online).
How often have they been followed up?
At the time of this report, only wave 1 of the ELSA-HCAP
Sub-study has been completed. However, participants will
continue to be included in the ELSA main waves, so it is
expected that they will be followed up as part of the study.
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It is planned that ELSA will continue with assessments ev-
ery 2 years, nurse visits for biomarkers measurements ev-
ery 4 years and linkage with registry data, including
mortality statistics.
Data quality
To ensure data quality, two researchers scrutinized the
data collected, by comparing the results between various
tests and the overall performance on the Mini-Mental State
Examination (MMSE). The concordance between the dis-
tributions of ELSA-HCAP cognitive scores with those pub-
lished in similar age-matched population studies was also
examined. When outliers were identified (63 standard
deviations from the mean), further checks of the paper tests
and interview records were made, correcting any errors in
data entry (n¼ 48).
What has been measured?
The HCAP comprises two interviews, one with the respondent
and one with an informant nominated by the respondent.
The HCAP respondent interview covers a broad range
of cognitive domains (memory, language, executive
function, psychomotor speed, problem solving and numer-
acy) known to be affected by the ageing process. Table 2
summarizes these tests, the majority of which are new to
ELSA, although they all are well-established neurocogni-
tive assessments such as Mini-Mental State Examination
(MMSE), CERAD (Consortium to Establish a Registry for
Alzheimer’s Disease), Word List Memory, Backward
Counting Task, Community Screening Interview for
Dementia, Logical memory (East Boston Memory Test and
‘Anna Thompson’ story of the Wechsler Memory Scale),
CERAD Constructional Praxis (shape drawing), Symbol
Digit Modalities Test, HRS Number Series, Raven’s
Standard Progressive Matrices Test, and Trail Making. For
more detail and references, see Supplementary Table S2,
available as Supplementary data at IJE online. The 11-item
version of the Center for Epidemiologic Studies Depression
Scale (CES-D) was also administered, together with an op-
tional test of olfaction (smell), evaluating odour identifica-
tion and detection. The duration of the ELSA-HCAP
respondent interview was approximately 1 h (range 17.6–
186.2 min, median 72.8 min).
The ELSA-HCAP informant interview was conducted
with a nominated family member or knowledgeable friend
Figure 1 The flow of respondents and informant selection through the study in the English Longitudinal Study of Ageing Harmonised Cognitive
Assessment Protocol (ELSA-HCAP)
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who was asked to describe the general health of the respon-
dent and evaluate any changes in their cognitive abilities.
The interview measured the functional status of the respon-
dent, such as their ability to engage in activities of daily liv-
ing and social, and leisure activities. It also determined
whether the respondent had been previously diagnosed with
a stroke, Alzheimer’s disease, other forms of dementia or
Parkinson’s disease. Further measures included were the
Informant Questionnaire on Cognitive Decline in the
Elderly, Blessed Dementia Rating Scale, Community
Screening Instrument for Dementia (CSI-D) Cognitive
Activities Questionnaire, 10/66 Dementia Research Group
Informant Questionnaire and HRS Activities Questionnaire,
comprising questions related to the amount of time spent
watching TV, reading, doing household chores, yoga or
other exercises (see Table 2 and Table S2). The length of
time for which the informant had known the respondent
was also recorded. The informant interview was completed
either via a paper self-completion questionnaire or by a tele-
phone interview using computer-assisted telephone inter-
viewing. The ELSA-HCAP informant interview took
approximately 20–25 min to complete.
What has it found? key findings and
publications
The ELSA-HCAP Sub-study provides a detailed neuropsy-
chological and clinical assessment of a selected sample of
individuals aged 65 and over which can be extrapolated to
the rest of the ELSA population and, by extension, to those
living in the community in England. Table 3 shows the
sociodemographic characteristics of the ELSA-HCAP re-
spondent sample. Gender differences were observed in edu-
cational attainment and wealth, with more men attaining a
higher level of education and achieving higher wealth than
women. Men were more likely than women to be married
or living with a partner and to smoke or drink frequently.
In contrast, women were more likely to feel lonely and ex-
perience difficulties in the Instrumental Activities of Daily
Living, particularly using a map, shopping or working
around the house/gardening. Table 4 presents the weighted
means and standard deviation for each cognitive test in-
cluded in the ELSA-HCAP respondent interview. The per-
formance of men was on average better than women on
the MMSE, verbal fluency, backwards counting, construc-
tional praxis, logical reasoning (number series) and solving
intelligence tests (Ravens). Women outperformed men in
memory and visual-spatial scanning abilities (letter
cancellation).
The longitudinal nature of ELSA provides opportunities
for the investigation of precursors of cognitive impairment
and dementia over the 16 years of data, including the role
of demographic, economic, social, cognitive, behavioural,
biological and health factors. These in-depth phenotype
data provide important avenues to address the timing, du-
ration and multifactorial nature of the many biological,
Table 1 The response among ELSA-HCAP respondents and informants (eligible and completed interviews)
ELSA-HCAP respondent ELSA-HCAP informant
Group Category Eligible Completed interviews Completed interviews
n n % n %
Sex Male 742 573 77.2 371 –
Female 942 700 74.3 679 –
Age <65 – – – 375 –
65–69 376 301 80.1 174 –
70–74 391 299 76.5 183 –
75–79 339 259 76.4 154 –
80–84 328 249 75.9 108 –
85–89 162 114 70.4 27 –
90 and over 88 51 57.9 – –
Missing – – – 23 –
Cognitive group-
ing selection
1: Low 282 179 63.5 154 86.0*
2: Moderate 540 419 77.6 364 86.9*
3: Normal 862 675 78.3 618 91.5*
1684 1273 75.6 1050 82.5*
ELSA-HCAP: English Longitudinal Study of Ageing-Harmonised Cognitive Assessment Protocol.
*Percentage response rates from the completed number of respondents.
1273 represents the total sample of ELSA-HCAP respondents and 1050 represents the total sample of ELSA-HCAP informants.
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medical and social factors that influence the onset of clini-
cal symptoms of dementia.
There have been >30 peer-reviewed articles published
using ELSA data on cognitive functioning and dementia
outcomes, covering a wide range of issues: see [https://
www.elsa-project.ac.uk/publications]. However, these
analyses preceded the implementation of HCAP Sub-study
and we have, therefore, outlined a selection of findings to
illustrate the broad spectrum of factors that can be related
to cognitive functioning and dementia.
In ELSA, information about dementia has to date been
captured through a self-reported physician diagnosis of de-
mentia or Alzheimer’s disease and informant (proxy inter-
views) evaluations via the Informant Questionnaire on
Cognitive Decline in the Elderly.10 A proxy interview is
usually carried out with a nominated person (e.g. a family
member) when the core member is not able or declines to
take part but consents that someone else can complete a
shorter interview on their behalf. These measures have
been used in a number of studies to model future trends of
dementia incidence11 and to investigate socioeconomic
determinants12 and other modifiable risk factors associated
with dementia13 such as social support,14 loneliness,15 digi-
tal literacy16 and social and cultural engagement,17 as well
as a range of non-modifiable risk factors such as stroke,18
sensory impairments,19 physical capability20 and frailty.21
Over the different waves of data collection, an array of
cognitive tests has been administered including measures
of verbal memory, orientation, verbal fluency and letter
cancellation, in addition to the assessment of basic
Table 2 The battery of tests included in the ELSA-HCAP respondent and informant interviews with the correspondence between
ELSA main waves
Neuropsychological domain ELSA-HCAP ELSA main waves
ELSA-HCAP respondent interview
Mini-Mental State Examination (MMSE) Multiple  X
HRS Telephone Interview for Cognitive Status (HRS-TICS)  
CERAD word list recall-immediate Memory   (alternative list)
Retrieval fluency Language  
Letter cancellation Visuospatial  
Backward count Attention  
10/66 (Community Screening Instrument for Dementia, CSI-D) Executive functioning  X
CERAD word list recall–delayed Memory   (alternative list)
East Boston memory test–immediate Memory  x
Wechsler memory scale-IVa–immediate Memory  X
CERAD word list recognition Memory  X
Constructional praxis–immediate Memory  X
Symbol-digit modalities test Executive functioning  X
Constructional praxis–delayed Visuospatial  X
Wechsler memory scale-IV–delayed Memory  X
East Boston memory test–delayed Memory  x
Wechsler memory scale-IV–recognition Memory  X
Number series Executive functioning  X
Raven’s standard progressive matrices Executive functioning  X
Trail making A & B Executive functioning  X
Center for Epidemiological Studies Depression Scale (CES-D) Depression  (11 items)  (8 items)
Smell test Olfaction  X
ELSA-HCAP informant interview Functional domain
Jorm informant questionnaire on cognitive decline in the
elderly (IQCODE)
Informant evaluation  
Blessed dementia rating scale-part 2 Informant evaluation  x
HRS activities questionnaire Informant evaluation  x
Community Screening Instrument for Dementia (CSI-D) cognitive
activities questionnaire
Informant evaluation  x
10/66 dementia research group informant questionnaire Informant evaluation  X
Blessed dementia rating scale–part 1 Informant evaluation  X
ELSA-HCAP: English Longitudinal Study of Ageing-Harmonised Cognitive Assessment Protocol; HRS, Health Retirement Study; CERAD, Consortium to
Establish a Registry for Alzheimer’s Disease.
aWechsler memory scale-IV story administered in this study was ‘Anna Thompson’.
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Table 3. Sociodemographic, lifestyle and health characteristics of the ELSA-HCAP sample
Overall sample Men Women
Mean (SD)/% Mean (SD)/% Mean (SD)/% P-value
n/variables 1273 573 (45%) 700 (55%)
Age 75.3 (6.6) 75.1 (6.4) 75.4 (6.7) 0.83
Educational attainment 0.001
No qualification 37.5% 33.2% 40.1%
Education to age 16 17.2% 15.7% 18.5%
Education to age 18 33.5% 34.4% 32.8%
Degree 11.8% 16.8% 7.8%
Wealth 0.001
Lowest 33.6% 28.2% 38.1%
Medium 33.1% 33.4% 32.9%
Highest 33.3% 38.5% 29.3%
Geographical region 0.91
North 5.8% 5.8% 5.9%
Yorkshire 10.5% 10.3% 10.6%
East Midlands 13.0% 12.6% 13.4%
East Anglia 11.1% 10.8% 11.3%
South East 11.9% 12.0% 11.7%
South West 12.6 13.8% 11.6%
West Midlands 7.1% 7.0% 7.1%
North West 17.1% 18.0% 16.4%
Wales 11.0% 9.8% 12%
Depressive symptomsa 2.9% 2.3% 3.4% 0.22
Poor eyesight 4.1% 4.1% 4.2% 0.91
Poor hearing 7.0% 8.2% 6.0% 0.13
Poor olfaction 7.3% 7.5% 7.2% 0.83
Poor general health 10.1% 10.0% 10.1% 0.86
Cardiovascular condition 4.8% 5.8% 4.0% 0.15
Diabetes 5.3% 5.4% 5.2% 0.84
Hypertension 15.0% 15.0% 15.0% 0.99
Stroke 2.1% 2.8% 1.6% 0.13
Cancer 4.8% 5.2% 4.4% 0.51
Respiratory disease 4.6% 5.8% 3.6% 0.06
Activities of daily living
Difficulty dressing 11.8% 11.3% 12.2% 0.65
Difficulty walking 6.9% 5.9% 7.8% 0.24
Difficulty bathing 10.9% 9.3% 12.2% 0.10
Difficulty eating 2.0% 2.6% 1.4% 0.13
Difficulty getting out
of bed
4.9% 4.4% 5.3% 0.44
Difficulty using toilet 3.9% 3.3% 4.4% 0.30
Instrumental activities of
daily living
Difficulty using map 7.2% 5.6% 8.5% 0.05
Difficulty recognizing
danger
1.7% 2.1% 1.4% 0.37
Difficulty preparing a
meal
6.7% 5.9% 7.3% 0.33
Difficulty shopping 12.9% 9.6% 15.6% 0.001
Difficulty making calls 4.2% 4.9% 3.6% 0.25
Difficulty
communicating
4.7% 5.4% 4.2% 0.29
4.5% 4.2% 4.7% 0.64
(Continued)
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cognitive abilities such as numerical ability and literacy.
These have been used to investigate the relationship be-
tween cognitive performance and depressive symptoms,22
level of neighbourhood deprivation,23 diabetes,24 sensory
impairments25 and mortality.26 Furthermore, international
comparisons of cognitive performance have been con-
ducted across middle-aged and older adults in England and
the USA.27
What are the main strengths and
weaknesses?
The ELSA-HCAP used identical measures to the HRS-
HCAP, providing enhanced opportunities for international
comparisons of the broader biopsychosocial context of
cognitive impairment and algorithmic approaches to de-
mentia definition. Furthermore, the ELSA-HCAP battery
of tests has considerable overlap with other relevant stud-
ies such as the Cognitive Function and Ageing Studies
(CFAS),28 Aging, Demographics, and Memory Study
(ADAMS), Rush Memory and Aging Project29 and 10/66
dementia study.30
Several limitations should be acknowledged. The ELSA-
HCAP Sub-study is currently cross-sectional, and a follow-
up would be valuable to assess patterns of change in this
detailed extended neuropsychological battery. Adding neu-
roimaging to the study would also greatly enhance the re-
search possibilities of discriminating structural brain
changes related to healthy ageing from the level of abnor-
mal atrophy and neuronal loss associated with various neu-
rocognitive disorders. Combined with detailed functional
imaging, highlighting specific biochemical and molecular
processes could inform and refine diagnostic accuracy. An
important limitation is that the study sample is predomi-
nantly of White European ancestry. ELSA was designed to
be representative of the population of older people in
England in 2002 when only 3.2% of the older population
in England were from ethnic minorities, according to the
national census. Last, the number of ELSA-HCAP partici-
pants who were institutionalized at the time of the inter-
view was very low (n¼ 8), restricting generalization to
more fragile sectors of the population.
Some features that make the HCAP Sub-study distinc-
tive arise from it being embedded in ELSA. Several bio-
markers have been assessed in the study sample every
4 years since 2004. Study nurses have collected venous
blood for the determination of lipids (total cholesterol,
HDL cholesterol, triglycerides), glucose and glycated hae-
moglobin (HbA1c), inflammatory markers including C-re-
active protein, fibrinogen, and white blood cell counts,
ferritin and haemoglobin, insulin-like growth factor 1
(IGF1), vitamin D and other biomarkers that could be ana-
lysed longitudinally in relation to many ageing outcomes.
In addition to economic, psychosocial and health meas-
ures, genome-wide genotyping was carried out on 7412
ELSA participants of European ancestry, using the same
Illumina HumanOmni2.5 Beadchip as used in the HRS.
Polygenic risk scores for Alzheimer’s disease (AD) and de-
mentia have been created using results from the genome-
wide association study conducted by the International
Genomics of Alzheimer’s Project, and have been made
available through the UK Data Service. This offers a rich
resource of data for various analyses involving genome-
wide gene-environment or gene-gene interactions as well as
Table 3. Continued
Overall sample Men Women









7.2% 6.6% &0 .6% 0.51
Sedentary lifestyle 10.6% 10.3% 11.0% 0.67
Smoking 8.2% 8.6% 7.9 0.001
Drinking (daily) 20.7% 27.2% 15.2% 0.001
Married/living with
partner
64.6% 75.0% 54.3% 0.001
Feels lonely 6.8% 4.3% 9.1% 0.001
ELSA-HCAP: English Longitudinal Study of Ageing-Harmonised Cognitive Assessment Protocol.
aDepressive symptoms were ascertained using the threshold of 9 on the 11-item version of the Centre for Epidemiologic Studies Depression Scale (CES-D);
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the potential for Mendelian randomization analyses and
sub-phenotyping patient-stratification investigations.
Moreover, because participants in ELSA-HCAP will be
followed up in future waves of data collection, it will be
possible to quantify the consequences of severe cognitive
impairment for family income and expenditure, financial
decision making, social connectivity, mental well-being
and physical health. This information has the potential to
strengthen the evidence base for health and social care pro-
vision to this vulnerable sector of the population, and other
vital policy initiatives related to older fragile men and
women.
Can I get hold of the data? Where can I find
out more?
The ELSA-HCAP data, including the individual items and
the derived scores for each of the respondent and infor-
mant interviews, have been made available via UK Data
Service [https://ukdataservice.ac.uk]. The ELSA-HCAP
study number (SN) is 8502; http://doi.org/10.5255/UKDA-
SN-8502-2. The main ELSA study is SN 5050 and is held
under [http://doi.org/10.5255/UKDA-SN-5050-17]. The
person to contact for the ELSA-HCAP study is Dr Dorina
Cadar (e-mail: d.cadar@ucl.ac.uk).
Table 4 Descriptive statistics presenting weighted means and standard deviation of the cognitive tests included in the ELSA-
HCAP respondent interview
Overall sample Men Women
Cognitive test n Mean (SD) n Mean (SD) n Mean (SD) P-value
MMSE 1273 26.8 (3.3) 573 27.2 (3.0) 700 26.5 (3.5) 0.001
HRS-TICS 1271 2.8 (0.5) 572 2.8 (0.5) 699 2.7 (0.6) 0.10
CERAD immediate 1263 18.4 (5.1) 569 17.7 (4.9) 694 18.9 (5.2) 0.001
CERAD delayed 1264 5.5 (2.6) 568 5.2 (2.4) 696 5.8 (2.6) 0.001
CERAD recognition 1261 18.6 (2.5) 567 18.6 (2.2) 694 18.5 (2.7) 0.57
Retrieval fluency 1270 19.2 (8.5) 572 20.2 (8.8) 698 18.3 (8.2) 0.001
Letter cancellation 1186 269.1 (84.5) 542 258.6 (76.3) 644 278.3 (85.5) 0.001
Backwards counting 1253 31.5(10.9) 563 33.2(10.8) 690 30.1(10.9) 0.001
CSID 1271 4.0 (0.3) 572 4.0 (0.2) 699 3.9 (0.3) 0.01
EBMT story
immediate 1264 4.1 (1.5) 568 4.1 (1.5) 696 4.2 (1.5) 0.43
delayed 1217 2.9 (1.9) 546 2.8 (1.9) 671 2.9 (1.9) 0.22
Wechsler story
immediate 1254 9.3 (4.7) 565 9.2 (4.5) 689 9.4 (4.8) 0.28
delayed 1210 7.2 (4.7) 544 7.0 (4.6) 666 7.4 (4.8) 0.17
recognition 1222 11.3 (2.8) 549 11.4 (2.7) 673 11.3 (2.9) 0.57
CERAD Praxis
drawing 1250 9.5 (1.8) 564 9.9 (1.6) 686 9.2 (1.9) 0.001
delayed recall 1161 7.8 (2.8) 531 8.3 (2.7) 630 7.3 (2.8) 0.001
Symbol digit 1196 33.8 (12.6) 546 33.7 (11.9) 650 33.9 (13.1) 0.64
Number series 1153 530.4 (31.4) 528 536.3 (29.9) 625 525.3 (31.7) 0.001
Ravens 1258 13.6 (3.5) 567 14.1 (3.2) 691 13.2 (3.7) 0.001
Trail making A 1209 55.0 (34.9) 548 53.9 (35.8) 661 55.9 (34.1) 0.33
Trail making B 1038 116.1 (57.5) 487 115.1 (54.1) 551 116.9 (60.5) 0.65
ELSA-HCAP: English Longitudinal Study of Ageing-Harmonised Cognitive Assessment Protocol. MMSE, Mini-Mental Status Examination; HRS-TICS,
Health Retirement Study-Telephone Interview for Cognitive Status; CERAD, Consortium to Establish a Registry for Alzheimer’s Disease; CSI-D, Community
Screening Instrument for Dementia; EBMT, East Boston Memory Test.
Profile in a nutshell
• The Harmonised Cognitive Assessment Protocol
Sub-study of the English Longitudinal Study of
Ageing (ELSA-HCAP), comprising 1273 men and
women aged 65 and older, was set up in 2018 to as-
certain the prevalence of neurocognitive disorders
such as cognitive impairment and dementia and to
investigate the risk factors and regional variations in
these conditions across England.
• The ELSA-HCAP protocol represents a more exten-
sive range of cognitive measures than those col-
lected in regular waves of the English Longitudinal
Study of Ageing (ELSA), covering a broad range of
cognitive domains such as memory, language,
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Reasons to be cautious: Although ELSA benefits from repeated
measures over several years, of orientation, memory, verbal fluency
and letter cancellation, the more detailed ELSA-HCAP Sub-study is
currently cross-sectional. A follow-up ELSA-HCAP would be valu-
able to assess patterns of change. Adding neuroimaging would also
greatly enhance the research possibilities of this study. Other impor-
tant limitations are low ethnic diversity (the study population is pre-
dominantly of White European ancestry), and the limited number of
participants who were institutionalized at the time of the HCAP in-
terview (n¼8).
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